Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_assertion description "[Altogether, our findings identify Mdk as a pivotal factor involved in the resistance of glioma cells to THC pro-autophagic and antitumoral action, and suggest that selective targeting of the Mdk/ALK axis could help to improve the efficacy of antitumoral therapies for gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_assertion evidence source_evidence_literature NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_assertion SIO_000772 21233844 NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_assertion wasDerivedFrom befree-20140225 NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_assertion wasGeneratedBy ECO_0000203 NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.
- befree-20140225 importedOn "2014-02-25" NP215297.RAu7E73hFb5h1uUYpACekyneoUQUGEuZGY-Ad7f4YMNlQ130_provenance.